JP Morgan Chase’s Boston Scientific BSX Stock Holding History

JP Morgan Chase’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$39.6M	Buy	628,500 +407,200	+184%	+$32.6M	﹤0.01%	1534
2025 Q4	$21.1M	Buy	221,300 +9,100	+4%	+$892K	﹤0.01%	2019
2025 Q3	$20.7M	Buy	212,200 +16,400	+8%	+$1.7M	﹤0.01%	2069
2025 Q2	$21M	Buy	195,800 +88,000	+82%	+$8.9M	﹤0.01%	1921
2025 Q1	$10.9M	Sell	107,800 -220,100	-67%	-$22.2M	﹤0.01%	2468
2024 Q4	$29.3M	Sell	327,900 -5,000	-2%	-$440K	﹤0.01%	1689
2024 Q3	$27.9M	Buy	332,900 +92,100	+38%	+$7.26M	﹤0.01%	1730
2024 Q2	$18.5M	Buy	240,800 +69,700	+41%	+$5.1M	﹤0.01%	1925
2024 Q1	$11.7M	Buy	171,100 +63,600	+59%	+$4.09M	﹤0.01%	2343
2023 Q4	$6.21M	Sell	107,500 -259,500	-71%	-$13.9M	﹤0.01%	2897
2023 Q3	$19.4M	Buy	367,000 +296,700	+422%	+$15.6M	﹤0.01%	1705
2023 Q2	$3.8M	Buy	+70,300	New	+$3.67M	﹤0.01%	3089
2023 Q1	–	Sell	-59,200	Closed	-$2.74M	–	6709
2022 Q4	$2.74M	Hold	59,200	–	–	﹤0.01%	3317
2022 Q3	$2.29M	Sell	59,200 -4,000	-6%	-$160K	﹤0.01%	3358
2022 Q2	$2.35M	Buy	63,200 +44,600	+240%	+$1.82M	﹤0.01%	3406
2022 Q1	$824K	Sell	18,600 -773,100	-98%	-$33.5M	﹤0.01%	4402
2021 Q4	$33.6M	Buy	791,700 +180,000	+29%	+$7.56M	﹤0.01%	1434
2021 Q3	$26.5M	Buy	611,700 +18,600	+3%	+$823K	﹤0.01%	1556
2021 Q2	$25.4M	Hold	593,100	–	–	﹤0.01%	1637
2021 Q1	$22.9M	Buy	593,100 +80,600	+16%	+$3.05M	﹤0.01%	1640
2020 Q4	$18.4M	Buy	+512,500	New	+$18.5M	﹤0.01%	1684
2020 Q1	–	Sell	-100,000	Closed	-$4.52M	–	5315
2019 Q4	$4.52M	Hold	100,000	–	–	﹤0.01%	2763
2019 Q3	$4.07M	Hold	100,000	–	–	﹤0.01%	2863
2019 Q2	$4.19M	Buy	100,000 +50,000	+100%	+$1.92M	﹤0.01%	2772
2019 Q1	$1.92M	Sell	50,000 -95,000	-66%	-$3.63M	﹤0.01%	3353
2018 Q4	$5.12M	Hold	145,000	–	–	﹤0.01%	2552
2018 Q3	$5.58M	Buy	145,000 +50,000	+53%	+$1.75M	﹤0.01%	2662
2018 Q2	$3.11M	Hold	95,000	–	–	﹤0.01%	3063
2018 Q1	$2.6M	Hold	95,000	–	–	﹤0.01%	3083
2017 Q4	$2.35M	Buy	+95,000	New	+$2.62M	﹤0.01%	3223
2017 Q3	–	Sell	-22,800	Closed	-$632K	–	4969
2017 Q2	$632K	Sell	22,800 -52,400	-70%	-$1.39M	﹤0.01%	3628
2017 Q1	$1.87M	Buy	+75,200	New	+$1.83M	﹤0.01%	3082
2015 Q2	–	Sell	-700	Closed	-$12K	–	4025
2015 Q1	$12K	Sell	700 -11,700	-94%	-$185K	﹤0.01%	4004
2014 Q4	$164K	Sell	12,400 -28,800	-70%	-$368K	﹤0.01%	4057
2014 Q3	$487K	Buy	+41,200	New	+$519K	﹤0.01%	3677
2014 Q1	–	Sell	-400	Closed	-$5K	–	3615
2013 Q4	$5K	Hold	400	–	–	﹤0.01%	4054
2013 Q3	$5K	Sell	400 -500	-56%	-$5.41K	﹤0.01%	4343
2013 Q2	$8K	Buy	+900	New	+$7.63K	﹤0.01%	4347

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase's BSX Position: Q1 2026 in Review

JP Morgan Chase increased its Boston Scientific (BSX) stake by 31% in Q1 2026, buying an estimated $638M and bringing the position to 33,350,157 shares worth $2.1B. The position accounts for 0.13% of the portfolio, ranked #152.

JP Morgan Chase first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.18B in Q1 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

JP Morgan Chase held 33,350,157 shares of Boston Scientific worth $2.1B as of Q1 2026.
JP Morgan Chase bought 7,977,271 Boston Scientific shares in Q1 2026, an estimated $638M.
Boston Scientific made up 0.13% of JP Morgan Chase's portfolio in Q1 2026, its #152 holding.
JP Morgan Chase first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
JP Morgan Chase's Boston Scientific position peaked at $3.18B in Q1 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.